Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Investors

Check latest stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Bioniche Animal Health

English French 2008 2nd Quarter Results Webcast

December 18, 2007 — 11:30am ET

Watch Webcast

 

In the News

May 13, 2008
Bioniche Updates re: Mycobacterial Cell Wall Technology Platform


Other News

May 9, 2008
Bioniche Reports Fiscal 2008 Third Quarter

Disease Education for Patients & Caregivers In the Community

Disease Education What do you know about bladder cancer? It is the 4th most common cancer in men and the 8th most common cancer in women.  


Helping endangered species survive Assisted Reproductive Techniques (ART) Help Endangered Species Survival
There are approximately 110 Australian animal species classified as endangered, meaning they are likely to become extinct unless the various threats and pressures affecting them are removed.  

Clinical Trials Science

An interview with Dr. Francois Charette, Chief Medical Officer at Bioniche Life Sciences Inc.

An interview with Dr. Nigel C. Phillips, Chief Scientific Officer at Bioniche Life Sciences Inc.

Bioniche Life Sciences is the commercialization partner in the world’s first food safety vaccine: a cattle vaccine against E. coli O157:H7. The Company is scaling up production of the vaccine in order to ensure sufficient supply to meet Canadian demand following authorization from the Canadian Food Inspection Agency (CFIA) to distribute the vaccine to Canadian veterinarians. more

Canada's Top 10 Life Science Companies Competition Winner

Web system by: Creative Interactive eBusiness

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy